INVO Bioscience (INVO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

INVO INVO Bioscience

Watchlist

0.8400
+0.0179+2.18%

Close Aug 23 16:00 ET

0.8125
-0.0275-3.27%

Post 20:01 ET

3.28MMarket Cap1.22P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

INVO BioScience GAAP EPS of -$0.62, Revenue of $1.84M
Seeking AlphaAug 15 12:14 ET
Express News | INVO BioScience Q2 EPS $(0.62) Up From $(3.06) YoY; Revenue $1.826M Up From $315,902 YoY
BenzingaAug 14 09:08 ET
INVO Bioscience | 10-Q: Q2 2024 Earnings Report
SEC announcementAug 14 09:05 ET · Announcements
Express News | INVO Reports Record Second Quarter 2024 Financial Results With 481% Revenue Growth and a $1.1 Million Improvement to Adjusted Ebitda
ReutersAug 14 09:00 ET
Invo BioScience 2Q Rev $1.84M >INVO
Dow JonesAug 14 09:00 ET
Invo BioScience 2Q Loss $2.2M >INVO
Dow JonesAug 14 09:00 ET

Comments

Jaguar8

Aug 14 15:16

NEWS ER

$INVO Bioscience (INVO.US)$
INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
INVO Bioscience (Nasdaq: INVO) reported record Q2 2024 financial results, showcasing significant growth. Key highlights include:
- Revenue soared 481% year-over-year to $1,836,597
- Clinic revenue increased 611% to $1,807,921
- Total revenue from all clinics, including consolidated and equity method, grew 201% to $2,141,229
- Adjus...